O'Shaughnessy Asset Management, LLC Bridge Bio Pharma, Inc. Transaction History
O'Shaughnessy Asset Management, LLC
- $14.2 Billion
- Q2 2025
A detailed history of O'Shaughnessy Asset Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 4,766 shares of BBIO stock, worth $263,559. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,766Holding current value
$263,559% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding BBIO
# of Institutions
408Shares Held
187MCall Options Held
11.3MPut Options Held
2.2M-
Viking Global Investors LP18.6MShares$1.03 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$912 Million0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$733 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$688 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$513 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $8.2B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...